Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Anke Muth"'
Autor:
Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S. Hong, Sven D. Koch, Ulrike Gnad-Vogt, Alfred Zippelius
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Abstract Background Preclinical studies demonstrate synergism between cancer immunotherapy and local radiation, enhancing anti-tumor effects and promoting immune responses. BI1361849 (CV9202) is an active cancer immunotherapeutic comprising protamine
Externí odkaz:
https://doaj.org/article/99e04455f1444be88b66a788433ed6e0
Autor:
Ruben R Bender, Anke Muth, Irene C Schneider, Thorsten Friedel, Jessica Hartmann, Andreas Plückthun, Andrea Maisner, Christian J Buchholz
Publikováno v:
PLoS Pathogens, Vol 12, Iss 6, p e1005641 (2016)
Receptor-targeted lentiviral vectors (LVs) can be an effective tool for selective transfer of genes into distinct cell types of choice. Moreover, they can be used to determine the molecular properties that cell surface proteins must fulfill to act as
Externí odkaz:
https://doaj.org/article/0debb1fda0ce43198d000109c809c36a
Autor:
Irene C. Schneider, Alexander Muik, Anke Muth, Christian J. Buchholz, Robert C. Münch, Karen Patricia Hartmann, Johanna Reul, Thorsten Friedel
Publikováno v:
Biomaterials. 144:84-94
We have established a novel approach for the covalent coupling of large polypeptides to the surface of fully assembled adeno-associated viral gene transfer vector (AAV) particles via split-intein mediated protein-trans-splicing (PTS). This way, we ac
Autor:
Helge Bischoff, Claudia Stosnach, Wolfgang Hilbe, Alexandros Papachristofilou, Thomas Wehler, Miklos Pless, Sven D. Koch, Frank Griesinger, Tobias Seibel, Richard Cathomas, Georg Pall, Martin Früh, Ute Klinkhardt, Anke Muth, Ulrike Gnad-Vogt, Karl-Josef Kallen, Christian Weiss, Jürgen Alt, Birgit Scheel, Alfred Zippelius, Madeleine M. Hipp, Martin Sebastian, Mariola Fotin-Mleczek, Fatma Doener, Henoch S. Hong, Andreas Schröder, Michael Geißler
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Background Preclinical studies demonstrate synergism between cancer immunotherapy and local radiation, enhancing anti-tumor effects and promoting immune responses. BI1361849 (CV9202) is an active cancer immunotherapeutic comprising protamine-formulat
Autor:
Annemarie Honegger, Thorsten Friedel, Lydia Jasmin Hanisch, Christian J. Buchholz, Anke Muth, Hinrich Abken, Andreas Plückthun, Irene C. Schneider
Publikováno v:
Protein Engineering, Design and Selection. 28:93-106
An increasing number of applications require the expression of single-chain variable fragments (scFv) fusion proteins in mammalian cells at the cell surface membrane. Here we assessed the CD30-specific scFv HRS3, which is used in immunotherapy, for i
Autor:
Katja Sockel, Anke Mütherig, Martina Crysandt, Mathias Hänel, Richard Noppeney, Kerstin Schaefer-Eckart, Martin Kaufmann, Christoph Röllig, Johannes Schetelig, Sven Zukunft, Frank Fiebig, Aristoteles Giagounidis, Sebastian Scholl, Andreas Lück, Kathrin Rieger, Katharina Götze, Thomas Geer, Philipp Kiewe, Carsten Müller-Tidow, Hubert Serve, Claudia Baldus, Ulrich Kaiser, Stefan Mahlmann, Burkhard Schmidt, Stefani Parmentier, Thomas Illmer, Ruth Seggewiß-Bernhardt, Alexander Kiani, Hartmut Linde, Heinz Dürk, Michael Kramer, Desiree Kunadt, Katharina Schmidt-Brücken, Jana Hase, Susann Helas, Jan Moritz Middeke, Malte von Bonin, Uta Oelschlaegel, Gerhard Ehninger, Christian Thiede, Martin Bornhauser, Uwe Platzbecker
Publikováno v:
HemaSphere, Vol 7, p e09759ad (2023)
Externí odkaz:
https://doaj.org/article/acd4818220c24cd7946a96fe0e80f14b
Autor:
Ingmar Hoerr, Alexander Knuth, Alfred Zippelius, Tanja Strack, Jochen Probst, Ulrike Gnad-Vogt, Florian Von Der Muelbe, Djordje Atanackovic, Andreas Gröschel, Frank Mayer, Michael Thomas, Volker Wiegand, Henoch S. Hong, Anke Muth, Andreas Schröder, Lotta von Boehmer, Folker Schneller, Karl-Josef Kallen, Martin Sebastian, Thomas Lander, Jan Stöhlmacher, Birgit Scheel, Martin Reck, Sven D. Koch, Mariola Fotin-Mleczek, Helga Bernhard
Publikováno v:
Cancer immunology, immunotherapy : CII. 68(5)
CV9201 is an RNActive®-based cancer immunotherapy encoding five non-small cell lung cancer-antigens: New York esophageal squamous cell carcinoma-1, melanoma antigen family C1/C2, survivin, and trophoblast glycoprotein. In a phase I/IIa dose-escalati
Autor:
Andreas Plückthun, Christian J. Buchholz, Anke Muth, Jessica Hartmann, Thorsten Friedel, Irene C. Schneider, Andrea Maisner, Ruben R. Bender
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 6, p e1005641 (2016)
PLoS Pathogens, Vol 12, Iss 6, p e1005641 (2016)
Receptor-targeted lentiviral vectors (LVs) can be an effective tool for selective transfer of genes into distinct cell types of choice. Moreover, they can be used to determine the molecular properties that cell surface proteins must fulfill to act as
Autor:
Alexandra Trkola, Dorothee von Laer, Qi Zhou, Robert C. Münch, Cheick Coulibaly, Janine Kimpel, Winfried S. Wels, Anett Pfeiffer, Anke Muth, Camille Lévy, Katharina M. Uhlig, Els Verhoeyen, Janna Seifried, Udo F. Hartwig, Christian J. Buchholz
Publikováno v:
Journal of Immunology (Baltimore, Md.: 1950)
Journal of Immunology (Baltimore, Md.: 1950), 2015, 195 (5), pp.2493-2501. ⟨10.4049/jimmunol.1500956⟩
Journal of Immunology (Baltimore, Md.: 1950), 2015, 195 (5), pp.2493-2501. ⟨10.4049/jimmunol.1500956⟩
Playing a central role in both innate and adaptive immunity, CD4+ T cells are a key target for genetic modifications in basic research and immunotherapy. In this article, we describe novel lentiviral vectors (CD4-LV) that have been rendered selective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115ef4dfb190e626f18830c434700cb6
https://doi.org/10.5167/uzh-120427
https://doi.org/10.5167/uzh-120427
Autor:
Anke Muth, Els Verhoeyen, Dorothee von Laer, Alexandra Trkola, Christian J. Buchholz, Robert C. Münch, Camille Lévy, Janine Kimpel, Udo F. Hartwig, Janna Seifried, Winfried S. Wels, Katharina M. Uhlig, Qi Zhou
Publikováno v:
Molecular Therapy. 23
Playing a central role in both innate and adaptive immunity, CD4+ T cells are the key target for genetic modifications in basic research and immunotherapy. Specific and stable delivery of therapeutic genes into these cells is therefore highly desirab